Skip to Content

Reyataz

Licence status
Authorised:
Active substances
Atazanavir
Dosage Form
Capsule, hard
Licence number
EU/1/03/267/01-7
Licence holder
Bristol-Myers Squibb Pharma EEIG

Licence information

ATC code
J05AE Protease inhibitors, J05AE08 atazanavir
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued